IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg (ODESA)
This study is ongoing, but not recruiting participants.
Sponsor:
Asan Medical Center
Collaborators:
Dong-A University
Myongji Hospital
Seoul National University Bundang Hospital
Seoul St. Mary's Hospital
Chung-Ang University
Eisai Inc.
Information provided by (Responsible Party):
Jae-Hong Lee, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT02550665
First received: September 10, 2015
Last updated: July 15, 2016
Last verified: July 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2016 |
| Estimated Primary Completion Date: | July 2016 (Final data collection date for primary outcome measure) |